Terns Pharmaceuticals Inc 's (TERN) Outlook - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Terns Pharmaceuticals Inc   (NASDAQ: TERN)
 



  Terns Pharmaceuticals Inc Outlook

On May 13 2024 the Terns Pharmaceuticals Inc provided following guidance

Terns Pharmaceuticals Inc. has released its financial results for the first quarter of 2024 along with important corporate updates. The company is eagerly awaiting the interim data from the initial dose escalation cohorts from the Phase 1 CARDINAL trial of TERN-701, an allosteric BCR-ABL inhibitor, in Chronic Myeloid Leukemia (CML). This data is expected to be available in the second half of 2024.

The company is dedicated to advancing its pipeline of innovative therapies and looks forward to the results of this trial as they continue to make progress towards providing novel treatment options for patients with CML. The Phase 1 CARDINAL trial is a crucial step in evaluating the safety and efficacy of TERN-701, and the upcoming data will provide valuable insights into its potential as a treatment for CML.

Terns Pharmaceuticals is committed to bringing transformative therapies to patients in need and will continue to provide updates on the progress of TERN-701 and other programs in its pipeline. The company remains focused on advancing its mission to improve the lives of patients with serious diseases through innovative research and development efforts.





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.